国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (11): 824-826.

• 综述 • 上一篇    下一篇

泛素连接酶Pirh2在肿瘤中的研究进展

吴小荣, 刘东明   

  1. 200001,上海交通大学医学院附属仁济医院泌尿外科
  • 出版日期:2012-11-08 发布日期:2012-11-16
  • 通讯作者: 刘东明,E-mail: liudm541@126.com E-mail:liudm541@126.com

Pirh2 and tumor

WU  Xiao-Rong, LIU  Dong-Ming   

  1. Department of Urology Surgery, Renji Hospital, Shanghai Jiaotong University Medical School, Shanghai 200001, China
  • Online:2012-11-08 Published:2012-11-16
  • Contact: Corresponding author: LIU Dong-ming, E-mail: liudm541@126.com E-mail:liudm541@126.com

摘要: 泛素连接酶Pirh2是体内E3泛素连接酶的一种,可通过泛素-蛋白酶体途径介导p53降解,抑制p53的生物学功能。近来研究表明Pirh2在人体多种肿瘤细胞中呈过度表达,提示其可能参与肿瘤发生和发展过程,将来可能作为肿瘤基因治疗的一个潜在靶点。

关键词: 肿瘤, 泛素蛋白连接酶类, Pirh2

Abstract: Pirh2 (p53-induced protein with a Ring-H2 domain), one of the ubiquitin-protein E3 ligases, can promote p53 degradation via ubiquitin-proteasome pathway, and repress the biological functions of p53. Researchers have found that the Pirh2 is overexpressed in many cancers, which suggests Pirh2 is probably correlated with tumorigenesis and cancer development, and it may become a promising cancer therapeutic target.

Key words: Neoplasms, Ubiquitin-protein ligases, Pirh2